renal hyperparathyroidism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with end-stage renal disease on dialysis who had an indication for surgical treatment of SHPT, fulfilling one or more of the following criteria: (1) with severe symptoms; (2) high PTH levels (> 800 pg/mL); (3) the detection of one or more enlarged parathyroid gland (>500 mm3 or diameter greater than 1 cm); (4) hypercalcemia (> 4mmol/L) and/or hyperphosphatemia (>1.94mmol/L).
Exclusion criteria
Exclusion criteria: 1. Kidney transplant patients; 2. Patients with severe skeleton deformity or bone deformities; 3. Patients with severe heart, lung, brain dysfunction and other systemic diseases; 4. Patients with severe coagulation dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptomatic improvement;PTH, Ca, P, ALP;Hypocalcaemia rate;requirement of vitamin D analogs;recurrence/persistent rate;time to recurrence;reoparation rate; | — |
Countries
China
Contacts
Zhongnan Hospital of Wuhan University